Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 2Phase 1 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Small Cell Lung Carcinoma 3Non-squamous Non-small Cell Lung Cancer 3Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Breast Neoplasms 2Lung Neoplasms 1Liver Neoplasms 1Esophageal Squamous Cell Carcinoma 1ESCC 1Desmoid Tumors 1Advanced Solid Tumor 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × anlotinib × Clear all
NCT06605690 2024-09-20

An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer

The Affiliated Hospital Of Guizhou Medical University

Phase NA Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

NCT06015126 2023-08-29

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients

Xi'an International Medical Center Hospital

Phase NA Unknown
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡